Abstract
Financial incentives (pay for performance) for clinicians are an intuitively reasonable solution to the well documented gaps between evidence based best practice and routine care.1 They were fundamental to the 2004 Quality and Outcomes Framework (QOF), which paid primary care physicians in England up to 25% of their income for achieving 147 performance indicators, including 76 clinical targets (such as recording smoking behaviour, keeping blood pressure and cholesterol levels below targets, and spirometry in patients with asthma).2 Whether the cost (around an extra £1bn (€1.3bn; $1.6bn) annually) was justified has been contested. Similar attempts include over 170 initiatives in public and private US hospitals, and Australia’s Medicare Practice Incentives Program, which targets quality in primary care.
| Original language | English |
|---|---|
| Article number | e5047 |
| Journal | British Medical Journal |
| Volume | 345 |
| Issue number | 7870 |
| DOIs | |
| Publication status | Published - 18 Aug 2012 |
Fingerprint
Dive into the research topics of 'When financial incentives do more good than harm: A checklist'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver